infectious diseases

News

UK experts call for meningitis shots for all 15-year-olds

All 15-year-olds in the UK should be offered the meningitis B vaccine following the fatal outbreaks earlier this year, says the JCVI.

News

First trial of Bundibugyo Ebola vaccine starts in UK

Oxford University has launched what it says is the world's first phase I trial of a vaccine specifically designed to protect against Bundibugyo Ebola.

News

Non-profit DNDi preps phase 3 trials for dengue antibody

Non-profit DNDi has licensed a dengue therapy from India's SII, paving the way for a phase 3 trial in Malaysia, Thailand, and Brazil.

News

Moderna's mResvia gets shot in the arm from EU contract

A new EU procurement contract could give Moderna's RSV shot mResvia, which has struggled to gain traction in the market, a welcome boost.

News

Trial of Bundibugyo Ebola drugs starts in DRC

Patients are now being enrolled in a trial of two potential therapies for Bundibugyo Ebola, Mapp's MBP134 and Gilead's remdesivir, says WHO.

News

UK's RQ Bio raises $115m for flu prevention drug

RQ Bio has raised $115m for clinical trials of RQB01, a one-shot antibody designed for strain-agnostic protection against seasonal influenza viruses.

UK experts call for meningitis shots for all 15-year-olds

First trial of Bundibugyo Ebola vaccine starts in UK

Non-profit DNDi preps phase 3 trials for dengue antibody

Moderna's mResvia gets shot in the arm from EU contract

Trial of Bundibugyo Ebola drugs starts in DRC

UK's RQ Bio raises $115m for flu prevention drug

UK's Mission divests kidney drug to Dimerix for $292m

Discover a new era of healthcare panel engagement: Grounded ...

infectious diseases

Editor's Picks